Life science

In our investment portfolio, we have companies that develop solutions that previously were considered impossible, but now becomes more and more real.

EffRx Pharmaceuticals S.A.

EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients.

Promore Pharma

Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company’s aim is to develop two first-in-category products for indications with very few efficacious prescription pharmaceuticals, addressing high unmet medical need.

Chrodate Medical

Chordate is a medical technology company. Over the past 10 years they have developed, patented and CE-marked a new treatment method for chronic rhinitis using neurostimulation. They are currently conducting a trial to also include chronic migraine to our treatment areas.

Oblique Therapeutics

Oblique Therapeutics is a curiosity-driven, innovative biotech company with strong scientific acumen and drive for increasing the bandwidth of antibody therapeutics, focusing on pain and aggressive-metastatic cancer.